GlassScriptPhysician profile
Ashley Elizabeth Prosper
NPI 1932534492
$34,398.07
in general payments reported to CMS, 2019-2025
9 companies · $17K in 2025
The $17K reported for 2025 was more than what 98% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2022: $260 · 2023: $308 · 2024: $1,681 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Honoraria: $1,500 · Food and Beverage: $1,294 · Travel and Lodging: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,524.00 |
| Honoraria | $1,500.00 |
| Food and Beverage | $1,294.01 |
| Travel and Lodging | $1,121.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare LLC | $17,144.39 | 2025 | |
| Siemens Medical Solutions USA, INC. | $15,285.57 | 2019-2024 | Magnetom Vida, Naeotom Alpha |
| Canon Medical Informatics, INC. | $1,500.00 | 2024 | Vitrea Advanced Visualization |
| Edwards Lifesciences Corporation | $171.78 | 2025 | Evoque |
| Astrazeneca Pharmaceuticals LP | $134.76 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $57.42 | 2022 | |
| Cleerly, INC. | $56.02 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Heartflow, INC. | $25.56 | 2023 | Ffrct |
| Ge Healthcare | $22.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Prosper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.